Location: Dorado, Puerto Rico
CIK: 0001910456 · Show all filings
Period: Q2 2026 (← Previous)
Filing Date: Aug 12, 2026
Total Value: $508M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PLRX | PLIANT THERAPEUTICS INC | 1,798,070 | $2.05M | 0.4% | $1.14 | — | COM | 729139105 |
| FHTX | FOGHORN THERAPEUTICS INC | 61,588 | $301K | 0.1% | $4.88 | — | COM | 344174107 |
| AVTX | AVALO THERAPEUTICS INC | 10,100 | $187K | 0.0% | $18.48 | — | COM NEW | 05338F306 |
| NUVB | NUVATION BIO INC | 16,029 | $91,045 | 0.0% | $5.68 | — | COM CL A | 67080N101 |
| EPRX | EUPRAXIA PHARMACEUTICALS INC | 10,000 | $66,100 | 0.0% | $6.61 | — | COM | 29842P105 |
| IKT | INHIBIKASE THERAPEUTICS INC | 20,000 | $40,600 | 0.0% | $2.03 | — | COM NEW | 45719W205 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| AGIO | AGIOS PHARMACEUTICALS INC | 3,408,937 (+30.5%) | $127M (+43.2%) | 24.9% | $30.32 | — | COM | 00847X104 |
| CCCC | C4 THERAPEUTICS INC | 7,326,691 (+4.7%) | $34.22M (+85.9%) | 6.7% | $4.48 | — | COM STK | 12529R107 |
| PASG | PASSAGE BIO INC | 673,759 (+8.0%) | $3.288M (-32.8%) | 0.6% | $6.81 | — | COM NEW | 702712209 |
| TRAW | TRAWS PHARMA INC | 559,470 (+3610.5%) | $472K (+1609.9%) | 0.1% | $0.87 | — | COM NEW | 68232V884 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| GHRS | GH RESEARCH PLC | 10,763,288 | $151M | 29.8% | $11.25 | — | — | G3855L106 |
| IMTX | IMMATICS N.V | 216,973 | $2.135M | 0.4% | $10.09 | — | — | N44445109 |
| DSGN | DESIGN THERAPEUTICS INC | 119,516 | $1.272M | 0.3% | $7.04 | — | — | 25056L103 |
| IBIO | IBIO INC | 68,076 | $129K | 0.0% | $2.31 | — | — | 451033708 |
| PRQR | PROQR THRAPEUTICS N V | 68,486 | $111K | 0.0% | $2.34 | — | — | N71542109 |
| ABSI | ABSCI CORPORATION | 21,245 | $63,735 | 0.0% | $3.00 | — | — | 00091E109 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| DNLI | DENALI THERAPEUTICS INC | 11,658 (-99.4%) | $300K (-99.2%) | 0.1% | $16.74 | — | COM | 24823R105 |
| STOK | STOKE THERAPEUTICS INC | 4,038,404 (-15.2%) | $132M (-14.8%) | 26.0% | $8.00 | — | COM | 86150R107 |
| XNCR | XENCOR INC | 18,194 (-96.6%) | $293K (-95.5%) | 0.1% | $14.94 | — | COM | 98401F105 |
| DTIL | PRECISION BIOSCIENCES INC | 950,466 (-3.5%) | $7.471M (+37.9%) | 1.5% | $6.69 | — | COM NEW | 74019P207 |
| TRDA | ENTRADA THERAPEUTICS INC | 178,606 (-15.6%) | $1.315M (-50.8%) | 0.3% | $12.05 | — | COM | 29384C108 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CGEM | CULLINAN THERAPEUTICS INC | 8,963,500 | $163M | 32.2% | $9.81 | — | COM | 230031106 |
| KRRO | KORRO BIO INC | 1,538,296 | $20.27M | 4.0% | $16.34 | — | COM | 500946108 |
| HOWL | WEREWOLF THERAPEUTICS INC | 657,786 | $237K | 0.0% | $1.22 | — | COM | 95075A107 |
| NEUP | NEUPHORIA THERAPEUTICS INC | 875,328 | $3.825M | 0.8% | $7.10 | — | COM | 64136E102 |
| TCRX | TSCAN THERAPEUTICS INC | 8,019,148 | $7.86M | 1.5% | $2.30 | — | COM | 89854M101 |
| CGON | CG ONCOLOGY INC | 31,391 | $2.23M | 0.4% | $41.38 | — | COM | 156944100 |
| VYNE | VYNE THERAPEUTICS INC | 1,628,700 | $1.06M | 0.2% | $0.57 | — | COM | 92941V308 |
| BOLT | BOLT BIOTHERAPEUTICS INC | 30,800 | $119K | 0.0% | $5.73 | — | COM NEW | 097702203 |